ReviewCNS drugs2012

Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.

Susan DutyPubMed ↗Publisher ↗

No numbers read from the abstract.